Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence
Author:
Publisher
Baishideng Publishing Group Inc.
Subject
Gastroenterology,General Medicine
Reference56 articles.
1. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆
2. Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
3. Recommendations for the treatment of Crohnʼs disease with tumor necrosis factor antagonists: An expert consensus report
4. Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
5. Review article: causative factors and the clinical management of patients with Crohn’s disease who lose response to anti-TNF-α therapy
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Pharmaceuticals and Therapeutics for Tumor Necrosis Factor-Alpha-Resistant Crohn's Disease: A Narrative Review;Cureus;2024-07-25
2. Biologics in Focus: A Comprehensive Review of Current Biological and Small Molecules Therapies for Crohn’s Disease in the United Arab Emirates (UAE);Gastrointestinal Disorders;2024-07-07
3. O USO DO VEDOLIZUMBABE NO TRATAMENTO DA DOENÇA DE CRONH: UMA REVISÃO INTEGRATIVA;REVISTA FOCO;2024-07-02
4. Macrophage: Hidden Criminal in Therapy Resistance;Journal of Innate Immunity;2024
5. IBDTransDB: a manually curated transcriptomic database for inflammatory bowel disease;Database;2024-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3